http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105267165-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
filingDate 2014-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105267165-B
titleOfInvention A kind of preparation method of Nitrendipine Tablet
abstract The invention discloses a kind of preparation method of Nitrendipine Tablet, comprise the following steps:(1) 8 12 parts of nitrendipine, 45 55 parts of cellulose milk sugar, 10 14 parts of low-substituted hydroxypropyl cellulose, 1.8 parts of silica 1 .2,0.3 0.5 parts of magnesium stearate are weighed by weight;(2) cellulose milk sugar, low-substituted hydroxypropyl cellulose, silica are crossed into 100 140 mesh sieve 46 times respectively, mixing, nitrendipine is added into mixed-powder, it is well mixed, 100 140 mesh sieve 46 times are crossed, add magnesium stearate, with 25 30 revs/min of rotating speed, mix 20 30 minutes, obtain intermediate powder, the angle of repose for controlling intermediate powder is 21 23 degree;(3) intermediate powder is subjected to tabletting, tableting pressure 80KN, pellet diameter 5.5mm, depth of fill 3mm, obtains plain piece.The present invention carries out the preparation of tablet using direct powder compression, without high temperature drying, without softwood processed, avoids influence of the temperature and humidity factor to drug crystal forms, preferably maintains the advantage crystal formation of medicine.
priorityDate 2014-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4840960-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161266530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415756263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448489261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54707177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453275488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525

Total number of triples: 42.